HM Payson & Co

SEC CIK: 0000928052
Latest filing: Jul 17, 2026

SEC filings (opens in a new tab)

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overview All 13F holders of DNLI Full Q2 2026 holdings

Shares (Q2 2026): 200
Value: $5.14K
% of portfolio: <0.1%
Quarters held: 3; Since Q1 2021

Holdings of DNLI by HM Payson & Co, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	200	$5.14K	<0.1%	+200	New	Holders
Q1 2022	0	$0	0.0%	−578−100.0%	Sold out	Holders
Q4 2021	578	$26.0K	<0.1%	+578	New	Holders
Q2 2021	0	$0	0.0%	−1,013−100.0%	Sold out	Holders
Q1 2021	1,013	$58.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.